1-4 of 4
Beatrix Wonke
Close
Sort by
Journal Articles

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

Clinical Trials & Observations
Dudley J. Pennell, Vasili Berdoukas, Markissia Karagiorga, Vasili Ladis, Antonio Piga, Athanassios Aessopos, Efstathios D. Gotsis, Mark A. Tanner, Gill C. Smith, Mark A. Westwood, Beatrix Wonke, Renzo Galanello
Journal: Blood
Blood (2006) 107 (9): 3738–3744.
https://doi.org/10.1182/blood-2005-07-2948
Published: 2006
Journal Articles

Normalized Left Ventricular Volumes and Function in Thalassemia Major Patients with Normal Myocardial Iron.

Mark A. Westwood, MD, Lisa J. Anderson, MD, Alicia M. Maceira, MD, Emma Prescott, BSc, John B. Porter, PhD, Beatrix Wonke, MD, Malcolm J. Walker, MD, Dudley J. Pennell, MD
Journal: Blood
Blood (2005) 106 (11): 2707.
https://doi.org/10.1182/blood.V106.11.2707.2707
Published: 2005
Journal Articles

The Safety and Pharmacokinetics of Deferitrin, a Novel Orally Available Iron Chelator.

Joanne M. Donovan, MD, Anne Yardumian, MD, Kulasiri A. Gunawardena, MD, Melissa A. Plone, Beatrix Wonke, MD
Journal: Blood
Blood (2004) 104 (11): 504.
https://doi.org/10.1182/blood.V104.11.504.504
Published: 2004
Journal Articles

Long-Term Trial of Deferiprone in 51 Transfusion-Dependent Iron Overloaded Patients

A. Victor Hoffbrand, Faris AL-Refaie, Bernard Davis, Noppadol Siritanakatkul, Beverly F.A. Jackson, John Cochrane, Emma Prescott, Beatrix Wonke
Journal: Blood
Blood (1998) 91 (1): 295–300.
https://doi.org/10.1182/blood.V91.1.295
Published: 1998